Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs Therapy for Subacute Intracerebral Hemorrhage
NCT06862388Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- Feb 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in intracerebral hemorrhage (ICH). Started Jun 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06862388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06862388.